← Leaderboards
David O'Neil
Excell Therapeutics, Llc
$245,176
Attributed
$245,176
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$245,176 · 1
By mechanism
R43$245,176 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Aftercare”
- Sharon A Nachman · Johns Hopkins University$78,205,219
- Mary M Horowitz · Medical College Of Wisconsin$74,193,785
- Dan H. Barouch · Fred Hutchinson Cancer Center$60,753,467
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
AftercareAllograft RejectionAntibodiesAntibody FormationAnti-Dna AntibodiesAntigensAnti-InflammatoryAnti-Inflammatory AgentsAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmunityAutologousBackBaseBloodB-LymphocytesBody SystemCd4 Positive T LymphocytesCd8b1 GeneCellsCell SeparationCell TherapyAdverse Effects